Mesenchymal stem cells alleviate systemic sclerosis by inhibiting the recruitment of pathogenic macrophages

Systemic sclerosis (SSc) is a recalcitrant autoimmune disease for which there is no cure. Mesenchymal stem cell (MSC)-based treatment has emerged as a promising therapeutic option for several autoimmune diseases. Previously, we found that the immunoregulatory potential of MSCs can be greatly enhance...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Pixia, Ding, Yayun, Sun, Rongrong, Jiang, Zishan, Li, Wen, Su, Xiao, Tian, Ruifeng, Zhou, Yipeng, Wang, Tingting, Jiang, Junjie, Li, Peishan, Shao, Changshun, Shi, Yufang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701228/
https://www.ncbi.nlm.nih.gov/pubmed/36435837
http://dx.doi.org/10.1038/s41420-022-01264-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701228/
https://www.ncbi.nlm.nih.gov/pubmed/36435837
http://dx.doi.org/10.1038/s41420-022-01264-2

Ejemplares similares